Cyclerion Therapeutics, Inc. filed its 10-K on Mar 22, 2023 for the period ending Dec 31, 2022. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.67 USD | -2.91% | -9.80% | -20.30% |
1st Jan change | Capi. | |
---|---|---|
-20.30% | 6.78M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- CYCN Stock
- News Cyclerion Therapeutics, Inc.
- Cyclerion Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt